z-logo
open-access-imgOpen Access
T Cell Response to Embryonal Carcinoma F9 Cells: Induction and Characterization of T Cell Receptor αβ + Double‐negative Cytotoxic T Lymphocytes
Author(s) -
Imada Mie,
Fujimoto Shigeyoshi
Publication year - 1993
Publication title -
japanese journal of cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 0910-5050
DOI - 10.1111/j.1349-7006.1993.tb02785.x
Subject(s) - cytotoxic t cell , biology , antigen presenting cell , major histocompatibility complex , microbiology and biotechnology , cd8 , interleukin 21 , natural killer t cell , il 2 receptor , lymphokine activated killer cell , antigen , t cell , immune system , immunology , in vitro , biochemistry
We investigated the mechanism of T cell response to marine embryonal carcinoma F9 cells. Thy‐1 + , CD4 − , CD8 − (double‐negative) cytotoxic effector cells were induced in spleen cells obtained from immune A.BY mice to F9 cells, and the cytotoxic activity was major histocompatibility complex (MHC)‐unrestricted. Furthermore, CD4 + T cells were essential for the induction of double‐negative cytotoxic T lymphocytes directed to F9 cells. Most of the double‐negative cytotoxic T lymphocyte lines obtained by long‐term culture of the effector cells had CD3 molecule and T‐cell receptor β chain on their cell surface, and the CDS molecule was found to be involved in target cell recognition. The T cell receptor αβ + double‐negative cytotoxic T lymphocyte line (2A5) also lysed various tumor cells in a non‐MHC‐restricted manner, but did not lyse concanavalin A‐stimulated blasts of 129 strain, from which F9 cells had originated. These results indicate that T cell receptor αβ + double‐negative cytotoxic T lymphocytes induced by F9 cells recognize a common antigen(s) expressed on F9 cells and other tumor cells but not minor histocompatibility antigens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here